This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
City Office REIT (CIO) Surpasses Q1 FFO and Revenue Estimates
by Zacks Equity Research
City Office REIT (CIO) delivered FFO and revenue surprises of 5.26% and 0.20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Physicians Realty Trust (DOC) Lags Q1 FFO Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of -3.57% and 2.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Douglas Emmett (DEI) Q1 FFO Meet Estimates
by Zacks Equity Research
Douglas Emmett (DEI) delivered FFO and revenue surprises of 0% and 15.51%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Alexander's (ALX) Tops Q1 FFO Estimates
by Zacks Equity Research
Alexander's (ALX) delivered FFO and revenue surprises of 0.71% and 1.96%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
National Health Investors (NHI) Tops Q4 FFO and Revenue Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of 0.95% and 1.94%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for December 31st
by Zacks Equity Research
GFF, NHI, ROCC, USFD, and TCMD have been added to the Zacks Rank #5 (Strong Sell) List on December 31, 2021.
New Strong Sell Stocks for November 11th
by Zacks Equity Research
BYND, REZI, THS, SANM, and NHI have been added to the Zacks Rank #5 (Strong Sell) List on November 11, 2021.
National Health Investors (NHI) Lags Q3 FFO and Revenue Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of -2.54% and -1.47%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
National Health (NHI) Sells Eight Assets Amid Operator Woes
by Zacks Equity Research
National Health (NHI) sells eight properties leased to Holiday for gross proceeds of $115 million. To date, it has received 85.6% of contractual cash due for third-quarter 2021.
National Health Investors (NHI) Q2 FFO and Revenues Lag Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of -7.20% and -2.08%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
National Health Investors (NHI) collects 77.5% of May Rents
by Zacks Equity Research
National Health Investors (NHI) collects 81.5% of second-quarter rents through May. While occupancy levels might improve in the upcoming period, rent deferrals will likely hinder revenue growth.
National Health Investors (NHI) Misses Q1 FFO Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of -4.62% and 0.13%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
American Tower (AMT) Announces $9.4B Deal to Buy Telxius Towers
by Zacks Equity Research
American Tower's (AMT) acquisition of 31,000 communications sites will enable it to accelerate property revenues and organic tenant billings growth, and scale business in Europe.
Is Recovery on the Horizon for Seniors Housing in 2021?
by Devyani Chamria
While vaccine deployment is driving share performance of healthcare REITs, surging cases of COVID-19 indicate that the rough terrain for the seniors housing market is likely to persist in 2021.
National Health (NHI) Notes Higher Rent Receipts, Occupancy Down
by Zacks Equity Research
National Health Investors (NHI) collects 92.7% of fourth-quarter rents. Yet, continued erosion in occupancy levels at its seniors housing portfolio is worrisome and will likely hinder revenue growth.
National Health Investors (NHI) Lags Q3 FFO Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of -0.70% and 2.09%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
NHI Provides Update on July Rents & Senior Housing Occupancy
by Zacks Equity Research
National Health Investors (NHI) collects 95.3% of August rents. Yet, the declining occupancy trend at its seniors housing portfolio in July is concerning.
National Health Investors (NHI) Surpasses Q2 FFO and Revenue Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of 2.10% and 1.43%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
NHI's Rent Receipts Strong, Senior Housing Occupancy Falls
by Zacks Equity Research
National Health Investors (NHI) collects 99.4% of rent in June to date. Yet, the declining occupancy trend at its seniors housing portfolio from March to May is concerning.
National Health Investors Enters JV to Buy Timber Ridge
by Zacks Equity Research
National Health Investors (NHI) agrees to buy Timber Ridge through a joint venture with Life Care Services to meet the growing demand for continuing care retirement community.
National Health Investors (NHI) Surpasses Q3 FFO and Revenue Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of 2.16% and 2.35%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
National Health Investors (NHI) Misses Q2 FFO Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of -0.73% and 1.42%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
National Health Investors (NHI) Q1 FFO Meet Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of 0.00% and 2.68%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
National Health Investors (NHI) Meets Q3 FFO Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of 0.00% and 0.93%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Prudential Financial (PRU) Q3 Earnings: A Beat in Store?
by Zacks Equity Research
Probable growth across businesses along with a possible revenue rise might aid Prudential Financial (PRU) in Q3.